Bank of New York Mellon Corp Has $117.43 Million Stock Holdings in Encompass Health Corporation (NYSE:EHC)

Bank of New York Mellon Corp reduced its stake in shares of Encompass Health Corporation (NYSE:EHC - Free Report) by 11.8% during the 1st quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 1,159,488 shares of the company's stock after selling 155,832 shares during the period. Bank of New York Mellon Corp owned 1.15% of Encompass Health worth $117,433,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also modified their holdings of the company. GAMMA Investing LLC grew its holdings in shares of Encompass Health by 21.5% during the 1st quarter. GAMMA Investing LLC now owns 2,366 shares of the company's stock valued at $240,000 after acquiring an additional 419 shares in the last quarter. Sequoia Financial Advisors LLC lifted its stake in shares of Encompass Health by 6.7% in the 1st quarter. Sequoia Financial Advisors LLC now owns 2,727 shares of the company's stock valued at $276,000 after purchasing an additional 172 shares during the last quarter. Cambridge Investment Research Advisors Inc. lifted its stake in shares of Encompass Health by 30.1% in the 1st quarter. Cambridge Investment Research Advisors Inc. now owns 9,597 shares of the company's stock valued at $972,000 after purchasing an additional 2,218 shares during the last quarter. Charles Schwab Investment Management Inc. lifted its stake in shares of Encompass Health by 0.7% in the 4th quarter. Charles Schwab Investment Management Inc. now owns 644,764 shares of the company's stock valued at $59,544,000 after purchasing an additional 4,345 shares during the last quarter. Finally, Fifth Third Bancorp lifted its stake in shares of Encompass Health by 88.7% in the 1st quarter. Fifth Third Bancorp now owns 4,290 shares of the company's stock valued at $434,000 after purchasing an additional 2,017 shares during the last quarter. 97.25% of the stock is currently owned by hedge funds and other institutional investors.

Insider Activity

In other news, insider Elissa Joy Charbonneau sold 4,279 shares of the company's stock in a transaction dated Tuesday, May 6th. The shares were sold at an average price of $116.61, for a total transaction of $498,974.19. Following the completion of the transaction, the insider owned 11,958 shares of the company's stock, valued at approximately $1,394,422.38. This represents a 26.35% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, EVP John Patrick Darby sold 10,000 shares of the company's stock in a transaction dated Tuesday, April 29th. The shares were sold at an average price of $114.79, for a total transaction of $1,147,900.00. Following the transaction, the executive vice president directly owned 79,710 shares of the company's stock, valued at $9,149,910.90. This represents a 11.15% decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 132,663 shares of company stock valued at $16,034,082. Insiders own 2.00% of the company's stock.

Encompass Health Stock Performance

Encompass Health stock traded up $1.07 on Friday, reaching $118.56. 358,412 shares of the stock were exchanged, compared to its average volume of 766,417. The firm has a fifty day moving average price of $119.54 and a two-hundred day moving average price of $106.03. The stock has a market cap of $11.95 billion, a PE ratio of 24.50, a PEG ratio of 2.39 and a beta of 0.88. The company has a current ratio of 1.06, a quick ratio of 1.06 and a debt-to-equity ratio of 0.81. Encompass Health Corporation has a twelve month low of $82.74 and a twelve month high of $123.13.

Encompass Health (NYSE:EHC - Get Free Report) last announced its quarterly earnings data on Thursday, April 24th. The company reported $1.37 EPS for the quarter, beating analysts' consensus estimates of $1.19 by $0.18. The business had revenue of $1.46 billion during the quarter, compared to analyst estimates of $1.43 billion. Encompass Health had a net margin of 8.97% and a return on equity of 17.63%. The firm's revenue for the quarter was up 10.6% on a year-over-year basis. During the same quarter in the prior year, the business earned $1.12 earnings per share. Sell-side analysts anticipate that Encompass Health Corporation will post 4.8 EPS for the current year.

Encompass Health Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, July 15th. Stockholders of record on Tuesday, July 1st will be given a dividend of $0.17 per share. This represents a $0.68 dividend on an annualized basis and a dividend yield of 0.57%. The ex-dividend date of this dividend is Tuesday, July 1st. Encompass Health's dividend payout ratio is currently 14.05%.

Wall Street Analyst Weigh In

EHC has been the subject of several analyst reports. UBS Group lifted their price objective on shares of Encompass Health from $117.00 to $130.00 and gave the company a "buy" rating in a research note on Monday, April 28th. Royal Bank Of Canada lifted their price objective on shares of Encompass Health from $110.00 to $125.00 and gave the company an "outperform" rating in a research note on Monday, April 28th. Wall Street Zen lowered shares of Encompass Health from a "strong-buy" rating to a "buy" rating in a research report on Friday, June 6th. Truist Financial reissued a "buy" rating and set a $135.00 target price (up previously from $116.00) on shares of Encompass Health in a research report on Monday, April 28th. Finally, Stephens raised shares of Encompass Health from an "overweight" rating to a "strong-buy" rating and set a $135.00 target price for the company in a research report on Thursday, June 5th. Seven analysts have rated the stock with a buy rating and one has assigned a strong buy rating to the company. According to data from MarketBeat.com, the stock presently has a consensus rating of "Buy" and an average target price of $131.50.

About Encompass Health

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.